We presented a novel likely pathogenic variant causing a compound heterozygous presentation of PLA2G6-associated INAD and demonstrated the clinical heterogeneity of this population. The gene discussed is PLA2G6; the disease is neurodegeneration with brain iron accumulation 2A.